Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels.

Yiu EM, Tai G, Peverill RE, Lee KJ, Croft KD, Mori TA, Scheiber-Mojdehkar B, Sturm B, Praschberger M, Vogel AP, Rance G, Stephenson SE, Sarsero JP, Stockley C, Lee CY, Churchyard A, Evans-Galea MV, Ryan MM, Lockhart PJ, Corben LA, Delatycki MB.

J Neurol. 2015 May;262(5):1344-53. doi: 10.1007/s00415-015-7719-2. Epub 2015 Apr 7.

PMID:
25845763
2.

Rescue of the Friedreich ataxia knockout mutation in transgenic mice containing an FXN-EGFP genomic reporter.

Sarsero JP, Holloway TP, Li L, Finkelstein DI, Ioannou PA.

PLoS One. 2014 Mar 25;9(3):e93307. doi: 10.1371/journal.pone.0093307. eCollection 2014.

3.

Pharmacological screening using an FXN-EGFP cellular genomic reporter assay for the therapy of Friedreich ataxia.

Li L, Voullaire L, Sandi C, Pook MA, Ioannou PA, Delatycki MB, Sarsero JP.

PLoS One. 2013;8(2):e55940. doi: 10.1371/journal.pone.0055940. Epub 2013 Feb 13.

4.

Mouse models for methylmalonic aciduria.

Peters HL, Pitt JJ, Wood LR, Hamilton NJ, Sarsero JP, Buck NE.

PLoS One. 2012;7(7):e40609. doi: 10.1371/journal.pone.0040609. Epub 2012 Jul 9.

5.

FXN methylation predicts expression and clinical outcome in Friedreich ataxia.

Evans-Galea MV, Carrodus N, Rowley SM, Corben LA, Tai G, Saffery R, Galati JC, Wong NC, Craig JM, Lynch DR, Regner SR, Brocht AF, Perlman SL, Bushara KO, Gomez CM, Wilmot GR, Li L, Varley E, Delatycki MB, Sarsero JP.

Ann Neurol. 2012 Apr;71(4):487-97. doi: 10.1002/ana.22671.

PMID:
22522441
6.

Long range regulation of human FXN gene expression.

Puspasari N, Rowley SM, Gordon L, Lockhart PJ, Ioannou PA, Delatycki MB, Sarsero JP.

PLoS One. 2011;6(7):e22001. doi: 10.1371/journal.pone.0022001. Epub 2011 Jul 8.

7.

Detection of interruptions in the GAA trinucleotide repeat expansion in the FXN gene of Friedreich ataxia.

Holloway TP, Rowley SM, Delatycki MB, Sarsero JP.

Biotechniques. 2011 Mar;50(3):182-6. doi: 10.2144/000113615.

8.

Generation of induced pluripotent stem cell lines from Friedreich ataxia patients.

Liu J, Verma PJ, Evans-Galea MV, Delatycki MB, Michalska A, Leung J, Crombie D, Sarsero JP, Williamson R, Dottori M, P├ębay A.

Stem Cell Rev Rep. 2011 Sep;7(3):703-13. doi: 10.1007/s12015-010-9210-x.

PMID:
21181307
9.

Gene induction for the treatment of methylmalonic aciduria.

Hu R, Buck NE, Khaniani MS, Wood L, Wardan H, Benoist JF, Li L, Vadolas J, Sarsero JP, Ioannou PA, Peters HL.

J Gene Med. 2009 Apr;11(4):361-9. doi: 10.1002/jgm.1297.

PMID:
19199343
10.

Integration of functional bacterial artificial chromosomes into human cord blood-derived multipotent stem cells.

Zaibak F, Kozlovski J, Vadolas J, Sarsero JP, Williamson R, Howden SE.

Gene Ther. 2009 Mar;16(3):404-14. doi: 10.1038/gt.2008.187. Epub 2009 Jan 29.

PMID:
19177134
11.

Transgenic mice expressing the Peripherin-EGFP genomic reporter display intrinsic peripheral nervous system fluorescence.

McLenachan S, Goldshmit Y, Fowler KJ, Voullaire L, Holloway TP, Turnley AM, Ioannou PA, Sarsero JP.

Transgenic Res. 2008 Dec;17(6):1103-16. doi: 10.1007/s11248-008-9210-7. Epub 2008 Aug 15.

PMID:
18709437
12.

Flow-cytometric analysis of mouse embryonic stem cell lipofection using small and large DNA constructs.

McLenachan S, Sarsero JP, Ioannou PA.

Genomics. 2007 Jun;89(6):708-20. Epub 2007 Apr 20.

13.

Evaluation of an FRDA-EGFP genomic reporter assay in transgenic mice.

Sarsero JP, Holloway TP, Li L, McLenachan S, Fowler KJ, Bertoncello I, Voullaire L, Gazeas S, Ioannou PA.

Mamm Genome. 2005 Apr;16(4):228-41.

PMID:
15965784
14.

Friedreich's ataxia, no changes in mitochondrial labile iron in human lymphoblasts and fibroblasts: a decrease in antioxidative capacity?

Sturm B, Bistrich U, Schranzhofer M, Sarsero JP, Rauen U, Scheiber-Mojdehkar B, de Groot H, Ioannou P, Petrat F.

J Biol Chem. 2005 Feb 25;280(8):6701-8. Epub 2004 Dec 22.

15.

Human BAC-mediated rescue of the Friedreich ataxia knockout mutation in transgenic mice.

Sarsero JP, Li L, Holloway TP, Voullaire L, Gazeas S, Fowler KJ, Kirby DM, Thorburn DR, Galle A, Cheema S, Koenig M, Williamson R, Ioannou PA.

Mamm Genome. 2004 May;15(5):370-82.

PMID:
15170226
16.

Upregulation of expression from the FRDA genomic locus for the therapy of Friedreich ataxia.

Sarsero JP, Li L, Wardan H, Sitte K, Williamson R, Ioannou PA.

J Gene Med. 2003 Jan;5(1):72-81.

PMID:
12516053
18.

A study of AroP-PheP chimeric proteins and identification of a residue involved in tryptophan transport.

Cosgriff AJ, Brasier G, Pi J, Dogovski C, Sarsero JP, Pittard AJ.

J Bacteriol. 2000 Apr;182(8):2207-17.

19.
21.

Some novel transcription attenuation mechanisms used by bacteria.

Yanofsky C, Konan KV, Sarsero JP.

Biochimie. 1996;78(11-12):1017-24. Review.

PMID:
9150880
23.
24.

Regulation of expression of the Escherichia coli K-12 mtr gene by TyrR protein and Trp repressor.

Sarsero JP, Wookey PJ, Pittard AJ.

J Bacteriol. 1991 Jul;173(13):4133-43.

25.

A new family of integral membrane proteins involved in transport of aromatic amino acids in Escherichia coli.

Sarsero JP, Wookey PJ, Gollnick P, Yanofsky C, Pittard AJ.

J Bacteriol. 1991 May;173(10):3231-4.

Supplemental Content

Loading ...
Support Center